Korean trial tests supercharged immune cells against deadly brain tumor
Disease control
Completed
This study tested whether adding a special immune cell therapy (Immuncell-LC) to standard chemotherapy (temozolomide) could better control a fast-growing brain cancer called glioblastoma. It involved 180 adults in Korea who were newly diagnosed and had recent surgery. Researchers…
Phase: PHASE3 • Sponsor: GC Cell Corporation • Aim: Disease control
Last updated Apr 02, 2026 07:26 UTC